Oncology Rounds

The latest news and research on cancer care from the Oncology Roundtable.

Upstate Cancer Center's initiative to prevent head and neck cancer through community education

by Deirdre Saulet and Kate Wister May 7, 2018

Head and neck cancers are relatively rare, making up only about 4% of cancers diagnosed. As a result, public awareness of the disease is relatively limited in comparison to more common tumor types, such as breast, lung, or prostate.

Read more »

An unintended side effect of cancer surgery: opioid dependence

by Deirdre Saulet and Julia Venanzi April 26, 2018

Due to the severity of the disease and treatment, opioids are a critical part of many cancer patients' chronic pain treatment plans. However, cancer patients are often excluded from the national conversation about opioid prescribing—and a new study shows this omission may be harmful.

Read more »

What you need to know about Medicare's physician supervision requirements

Deirdre Saulet March 29, 2018

CMS's physician supervision requirements continue to be an area of uncertainty and confusion for many of our members. Here, we have compiled the most up-to-date information on physician supervision for chemotherapy and radiation therapy.

Read more »

Your guide to oncology payment reform pilots

by Deirdre Saulet, Kate Wister and Elena Price March 26, 2018

We've seen payers and providers increasingly interested in experimenting with oncology payment models over the past few years. To assist cancer programs that are exploring alternative payments or just want to stay on top of this trend, we've provided examples and links to additional information below.

Read more »

Catching up with CAR-T: How centers are building out capabilities and struggling to get reimbursed

Deirdre Saulet March 12, 2018

When FDA approved two CAR-T cell therapies last year, it caused a groundswell of excitement across the country—but many questions remain around implementation and reimbursement. Keep reading to learn how one leading cancer center has reorganized its services to improve care for immunotherapy patients and how barriers to CAR-T reimbursement are raising concerns about access.

Read more »

What a colleague's breast health care experience taught us about genetic counseling

by Deirdre Saulet and Ashley Riley February 26, 2018

In a recent conversation with one of our Advisory Board colleagues, we were struck by how pivotal cancer genetic counseling services were in her decision of where to receive her breast health care. Our members frequently ask about the best ways to demonstrate the ROI for this poorly reimbursed service, so we want to share her story and explain how it should change your breast cancer program's strategy.


Read more »

How to help the 20% of cancer patients experiencing PTSD symptoms

by Deirdre Saulet and Soleil Shah February 9, 2018

Mental distress experienced before or after a cancer diagnosis can actually decrease patients' chances of survival. A new study published in Cancer looked at the prevalence of post-traumatic stress disorder (PTSD) among cancer patients. Keep reading to see what they found and how your cancer program can help.

Read more »

5 ways providers need to respond to payers' new patient assistance program approach

by Lindsay Conway January 30, 2018

As drug prices rise, a growing portion of infusion center patients have come to rely on drug manufacturers' patient assistance programs (PAPs). The aim of these programs is to ensure that patients can afford their drugs, regardless of their out-of-pocket cost. While PAPs take many forms, most offset or completely cover patients' copay, coinsurance, or deductible for drugs. 

Read more »